Main Menu

The U.S. Supreme Court Leaves the Door Open for a Wave of Off-Label Drug Marketing Claims under RICO . . . at Least in the First Circuit

Phil Wittmann and John Mark Fezio published the article, "The U.S. Supreme Court Leaves the Door Open for a Wave of Off-Label Drug Marketing Claims under RICO . . . at Least in the First Circuit" in the Winter 2014 issue of the American Bar Association Section of Antitrust Law, Business Torts & Civil RICO Committee's Business Torts & RICO News.  The article addresses the U.S. Supreme Court's denial of certiorari in Pfizer, Inc. v. Kaiser Foundation Health Plan, Inc. and how it may lead to a resurgence of RICO claims in the First Circuit. 

Attorneys

Back to Page